Recommendations for the use of neuroimaging for headaches issued by a number of national organizations, including the American Board of Internal Medicine Foundation’s Choosing Wisely initiative, could result in negative outcomes for patients with undiagnosed brain tumors, according to Ammar H. Hawasli, MD, PhD, of the Washington University School of Medicine in St. Louis.